Dystrophin contains multiple independent membrane-binding domains

Area of Science:

• Muscle biology
• Protein structure-function
• Molecular medicine

Background:

• Dystrophin is vital for muscle integrity, and its absence causes Duchenne muscular dystrophy (DMD).
• The cysteine-rich (CR) domain was previously thought to be solely responsible for dystrophin's sarcolemmal membrane binding.
• Understanding dystrophin's membrane interactions is key to developing effective DMD therapies.

Purpose of the Study:

• To identify and characterize all in vivo membrane-binding domains of dystrophin.
• To investigate the functional significance of these domains in sarcolemmal localization and DGC assembly.
• To provide a basis for engineering improved dystrophin variants for therapeutic applications.

Main Methods:

• Full-length dystrophin was divided into ten fragments.
• Adeno-associated virus-mediated gene transfer was used to examine fragment localization in skeletal muscle and heart.
• The ability of fragments to restore the dystrophin-associated glycoprotein complex (DGC) was assessed.

Main Results:

• Spectrin-like repeats (R)1-3, the CR domain, and the C-terminus (CT) exclusively localized to the sarcolemma in skeletal muscle.
• R10-12 exhibited both cytosolic and sarcolemmal localization.
• The CT domain alone was sufficient to restore DGC assembly, while R1-3 and R10-12 did not.
• R1-3 and CT showed weaker sarcolemmal binding in cardiac muscle.

Conclusions:

• Dystrophin possesses multiple independent membrane-binding domains, including R1-3, R10-12, and CT, in addition to the CR domain.
• These domains contribute to dystrophin's role as a sarcolemmal shock absorber and signaling hub.
• Findings offer insights into DMD pathogenesis and a foundation for developing targeted gene therapies for DMD.